SB-656104-A: A novel 5-HT7 receptor antagonist with improved In vivo properties
- 1 November 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 12 (22) , 3341-3344
- https://doi.org/10.1016/s0960-894x(02)00690-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Molecular, pharmacological and functional diversity of 5-HT receptorsPublished by Elsevier ,2002
- Subtype-Selective N-Methyl-d-Aspartate Receptor Antagonists: Synthesis and Biological Evaluation of 1-(Heteroarylalkynyl)-4-benzylpiperidinesJournal of Medicinal Chemistry, 2000
- Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonistBritish Journal of Pharmacology, 2000
- A Novel, Potent, and Selective 5-HT7Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)Journal of Medicinal Chemistry, 2000
- Characterization and distribution of putative 5‐ht7 receptors in guinea‐pig brainBritish Journal of Pharmacology, 1995
- Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation.Proceedings of the National Academy of Sciences, 1993
- A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythmsNeuron, 1993
- INDOLES FROM 2-METHYLNITROBENZENES BY CONDENSATION WITH FORMAMIDE ACETALS FOLLOWED BY REDUCTION: 4-BENZYLOXYINDOLEOrganic Syntheses, 1985